Goldman Sachs Group Inc Ani Pharmaceuticals Inc Put Options Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANIP
# of Institutions
210Shares Held
19.2MCall Options Held
3.4KPut Options Held
10.8K-
Black Rock Inc. New York, NY2.66MShares$156 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$77.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$58.9 Million0.03% of portfolio
-
State Street Corp Boston, MA737KShares$43.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX686KShares$40.3 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.02B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...